Plant Health Care gets fungicide approval in Brazil

Agricultural biological developer Plant Health Care announced on Friday that its biochemical fungicide PHC279, tailored for controlling sugar cane and coffee diseases, had obtained federal clearance in Brazil - the world's largest sugarcane and coffee producer.

Plant Health Care
18 August 2023 08:54:19

Source: Sharecast

The AIM-traded firm said that with an anticipated area of 9.8 million hectares dedicated to sugar cane cultivation and more than 2.5 million hectares of coffee in the 2023-2024 season, Brazil remained at the forefront of the industries.

Notably, during the 2021-2022 season, Brazilian agronomists disbursed more than $46m to combat sugar cane ailments, and $127m for coffee disease management.

Introduced for regulatory scrutiny in December, PHC279 - employed as a foliar-applied product - specifically targets sugar cane orange rust, or ‘Puccinia kuehnii’, and coffee leaf rust, or ‘Hemileia vastatrix’.

The board said the potent ingredient was also the foundation of ‘Saori’, another of Plant Health Care's offerings, which had garnered acclaim in Brazil for its efficacy as a soybean disease control seed treatment.

It explained that the genesis of PHC279 was in Plant Health Care's ‘PREtec’ technology platform, which it describes as ‘vaccines for plants’.

Based on natural proteins, the firm said PREtec propels crop growth, and equips them to resist diverse abiotic stresses, augmenting disease control, overall plant health, and yield.

Given its eco-friendly composition and its unique operational mechanism, PHC279 was set for a broad acceptance among the Brazilian community of sugarcane and coffee cultivators.

Currently, the company is engaging in conversations with potential collaborators, eyeing a product rollout in 2024.

“Building on the success of Saori use in soybeans and the continued growth of H2Copla use in sugarcane, this new registration will bring the benefits of PHC279 to sugar cane and coffee growers and expand Plant Health Care's current business in Brazil,” said chief executive officer Jeff Tweedy.

“This product will help Brazilian farmers sustainably produce crops and supports the company's vision to be a leading global provider of peptides for agricultural production.”

At 0824 BST, shares in Plant Health Care were up 10.16% at 10.3p.

Reporting by Josh White for Sharecast.com.

Transferring your account

Transfer your existing ISAs and Share Dealing Accounts and you could save money. In order to transfer, log in to your existing account and complete the online application form. We’ll do the rest for you. It’s free to transfer (we will not charge you). Please check your current provider to see if they have any charges for transferring.

Transfer to us

N/A

Isin: N/A

Exchange: N/A

Sell:

N/A

Buy:

N/A

Change:

Date:

Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

View our accounts

Bank of Scotland is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.

Important legal information

Bank of Scotland Share Dealing Service is operated by Halifax Share Dealing Limited. Halifax Share Dealing Limited. Registered in England and Wales No. 3195646. Registered Office: Trinity Road, Halifax, West Yorkshire HX1 2RG. Authorised and regulated by the Financial Conduct Authority, 12 Endeavour Square, London, E20 1JN under number 183332. A Member of the London Stock Exchange and an HM Revenue & Customs Approved ISA Manager.

The information contained within this website is provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd unless otherwise stated. The information is not intended to be advice or a recommendation to buy, sell or hold any of the shares, companies or investment vehicles mentioned, nor is it information meant to be a research recommendation. This is a solution powered by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd incorporating their prices, data news, charts, fundamentals and investor tools on this site. Terms and conditions apply. Prices and trades are provided by Allfunds Digital, S.L.U. acting through its business division Digital Look Ltd and are delayed by at least 15 minutes.

Data provided by FE fundinfo. Care has been taken to ensure that the information is correct, but FE fundinfo neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.